MDElliottMD: home-claude category backfill (parser-claude gap closure)

2026-05-23T10:43:28Z

home-claude category backfill (parser-claude gap closure)

← Older revision		Revision as of 10:43, 23 May 2026
Line 21:		Line 21:
	== References ==		== References ==
	<references />		<references />
			[[Category:Beta-2 adrenergic agonists]]
			[[Category:Bronchodilators]]

MDElliottMD: parser-claude batch MedTemplate pre-fill, Top 300 #7

2026-05-23T03:29:42Z

parser-claude batch MedTemplate pre-fill, Top 300 #7

New page

{{MedTemplate
| generic = Albuterol
| brand = Ventolin, ProAir, Proventil, AccuNeb
| structure =
| classes = [[:Category:Beta-2_adrenergic_agonists|Short-acting β2-agonist]], [[:Category:Bronchodilators|Bronchodilator]]
| uses = <vote slug="asthma-rescue-use">Asthma rescue</vote>, <vote slug="bronchospasm-use">Acute bronchospasm</vote>, <vote slug="eib-use">Exercise-induced bronchospasm</vote>, <vote slug="copd-exacerbation-use">COPD exacerbation</vote>
| starting_dose = MDI 90 mcg/puff, 2 puffs q4-6h prn; nebulized 2.5 mg in 3 mL saline q4-6h
| preparations = MDI 90 mcg/puff; nebulizer solution 0.083% (2.5 mg/3 mL), 0.5%, 0.021%, 0.042%; syrup 2 mg/5 mL; 2 mg, 4 mg tablets; 4 mg, 8 mg ER
| fda_max = 12 inhalations/d (rescue); higher for severe exacerbation under monitoring
| pill_id =
| routes = Inhaled (MDI, nebulized), Oral
| onset = Inhaled: 5-15 minutes; PO: 30 minutes
| duration = 4-6 hours
| halflife = 4-6 hours (inhaled and PO)<ref name="ventolin-label">FDA Prescribing Information, Ventolin HFA (albuterol sulfate), GlaxoSmithKline, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020983s039lbl.pdf</ref>
| bioavailability = ~10% inhaled reaches systemic circulation; ~50% PO<ref name="ventolin-label" />
| pregnancy = Preferred SABA in pregnancy; benefits of asthma control outweigh limited risks.{{citation needed}}
| legal = [[USLegal:Prescription only|Rx-only]] in US
| mechanism = <vote slug="albuterol-mech-claim">Albuterol is a short-acting selective β2-adrenergic agonist; receptor binding raises intracellular cAMP via Gs-protein-coupled adenylyl cyclase activation, relaxing bronchial smooth muscle within minutes.</vote> At higher doses β2 selectivity is lost, producing β1 effects (tachycardia, tremor) and hypokalemia from intracellular potassium shift<ref name="ventolin-label" />.
}}

== References ==
<references />

Albuterol - Revision history

MDElliottMD: home-claude category backfill (parser-claude gap closure)

MDElliottMD: parser-claude batch MedTemplate pre-fill, Top 300 #7